2023
Unlocking the Proteome - The NULISA™ Platform
Entrant Company
Halteres Associates
Category
Video, Commercial & Film - Medical
Client's Name
Alamar Biosciences
Country / Region
United States
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant Company
Halteres Associates
Category
Video, Commercial & Film - Consumer Health Product / Services
Country / Region
United States
Entrant Company
Courageous Studios
Category
Branded Content - Healthcare & Pharma
Country / Region
United States
Entrant Company
Elite Media
Category
Video, Commercial & Film - Insurance
Country / Region
United States
Entrant Company
Courageous Studios
Category
Video, Commercial & Film - Documentary
Country / Region
United States